What to Do if Your Clinician Is Unsure About Exercise During Treatment

Exercise oncology has advanced quickly: large reviews and consensus statements now conclude that, for most people with cancer, appropriately prescribed exercise is safe during and after treatment and can improve fitness, quality of life, and cancer‑related fatigue. Yet many clinicians still feel uncertain about recommending exercise during active treatment, often because of time constraints, limited training, or concerns about safety and interactions.​

If your clinician is unsure, there are respectful ways to share evidence, present your own data, and explore cautious options together.

Step‑by‑step advocacy in the visit

You can use a simple sequence: share guidelines, present your data, explore concerns, and propose solutions.

• 1. Share guidelines in plain language

  • Key message: Major expert groups agree that exercise, when tailored and monitored, is safe and beneficial for most people during and after treatment.​

  • You might say:

    • “The ACSM roundtable and other guidelines say that, with the right precautions, exercise can be part of treatment and helps with fatigue and function. I’d like your help applying that to me.”

• 2. Present your Curava data

  • Show what you are already tolerating:

    • “My Curava logs show I’ve been doing 5–10 minute light walks without dizziness or unusual symptoms.”

  • This moves the conversation from theory to your actual, recent experience.​

• 3. Address specific concerns directly

  • Ask: “What particular risks are you most concerned about with my chemotherapy, radiation, surgery, or other conditions?”

  • Examples of concerns: cardiotoxic treatments, low blood counts, bone metastases, severe neuropathy.​

  • Once the concerns are named, you can explore tailored solutions (for example, seated exercise with low fall risk, avoiding certain limb loading, or using stricter symptom stop‑rules).

• 4. Propose practical, conservative options

  • Suggestions might include:

    • A referral to physio or cancer rehab for a supervised starting plan.

    • Beginning with very light chair‑based exercises or short, slow walks on days when blood counts and symptoms allow.

    • Agreeing on clear red flags and check‑in points.​

This structure helps move from a general “no” toward a nuanced “yes, with conditions,” when appropriate.

Translating common clinician concerns into evidence‑informed responses

You do not need to argue statistics, but it can help to understand the general evidence behind common worries:

• Safety concerns (“Is it dangerous?”)

  • Evidence: The ACSM roundtable and subsequent reviews report that exercise interventions—many supervised—have low rates of serious adverse events when properly screened and monitored.​

  • Response: “I’d like to start with a plan that includes screening, clear stop‑rules, and, if needed, supervision. How might we do that here?”

• Fatigue concerns (“Will this exhaust you?”)

  • Evidence: Multiple meta‑analyses show that structured exercise reduces cancer‑related fatigue on average, rather than worsening it, especially when intensity and volume are matched to the individual.​

  • Response: “Could we try very short, low‑intensity sessions and see if they help my fatigue over a few weeks, with a plan to stop if it clearly makes things worse?”

• Interaction concerns (“Will it interfere with treatment?”)

  • Evidence: Trials generally show no negative impact on treatment completion or response; some data suggest improved functional reserve and treatment tolerance.​

  • Response: “I will track heart rate (if appropriate), symptoms, and any side effects in Curava and report back. Can we agree on specific signs that would mean we pause?”

These responses invite collaboration without dismissing legitimate caution.

Resources you can share 

Bringing a short, reputable summary—preferably one page or an infographic—can help:

• ACSM exercise guidelines / consensus statements:

  • These note that exercise is generally safe during and after treatment and provide broad recommendations for aerobic, resistance, and flexibility training for survivors.​

• Plain‑language articles, such as NCI pieces on “Prescribing Exercise as Cancer Treatment.”:

  • These summarize the evidence and emphasize the role of clinicians in supporting activity as part of care.​

You might say: “I brought this short summary because it helped me understand the evidence. Could we look at it together to see how it might apply to me?”

Using Curava to support safe implementation

Once you and your clinician reach some level of agreement:

• Implement the plan in Curava:

  • Choose session types and intensities consistent with what was agreed (for example, only light walking and chair exercises at first).

  • Track symptoms, including fatigue, pain, dizziness, heart rate (if advised), and any treatment‑related changes.​

• Report back with real‑world data:

  • At the next visit, share a brief Curava summary: what you did, how often, and how your symptoms changed.

  • This feedback can increase your clinician’s confidence or highlight where further adjustment is needed.

This approach aligns with broader survivorship recommendations encouraging patient‑reported outcomes and shared decision‑making.​

Clinician caution around exercise during treatment often reflects care and limited time or training, not opposition to your wellbeing. By bringing clear evidence, modest goals, Curava‑based data, and concrete solutions like supervised referrals, you can help transform a vague “I’m not sure” into a tailored, cautious “yes” when it is safe to do so.​

Your initiative does not replace medical judgment; it enriches it. Together, you and your clinician can shape an exercise plan that respects both the science and your current condition—making movement a safer, supported part of your treatment journey rather than an uncertain add‑on.